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individualized counseling to every patient and their caretakers at
every visit.
Objective: To determine the pharmaceutical care outcome of a
clinical pharmacist in the HF Clinic, by evaluating the extent of
dose optimization of guideline-recommended HF pharmacotherapy
and improvement in patient outcomes such as New York Heart
Association (NYHA) class and left ventricular ejection fraction (LVEF)
6 months after consistent follow up.
Materials & methods: Patients with HF reduced Ejection Fraction
(HFrEF) recruited into the HF Clinic between April 2016 and January
2018, and who have completed 6-month follow up were included.
Data was collected retrospectively. Baseline pharmacotherapy, NYHA
class and LVEF were recorded at the first clinic visit and compared
with corresponding parameters at 6 months.
Result: 100 patients were included. The cohort had a mean age
of 52.46 (±12.1) years. 83% were males, 36% had an ischemic
etiology, 29% had diabetes, 57% had hypertension and 22% had atrial
fibrillation. At baseline, use of beta blocker (BB), angiotensin-
converting enzyme inhibitor (ACEI) and mineralocorticoid receptor
antagonist (MRA) was 86%, 70% and 56% respectively. At 6 months,
this increased to 89%, 79% and 67% respectively. At baseline, those
achieving optimal dosage for BB, ACEI and MRA were 8%, 6% and 11%
respectively. At 6 months, this increased to 40%, 50% and 23%
respectively. Half of them had a reduced diuretic requirement by 50%
after 6 months. 29% of patients had symptomatic HF (NYHA class II
or more) at baseline, decreasing to 4% at 6 months. The improvement
in LVEF within 6 months was statistically significant (mean 37.3±
14.0 versus 27.5±9.8, pb0.001).
Conclusion: The dedicated clinical pharmacist in the HF clinic
reinforced the management strategy of the multidisciplinary team as
described above. This was manifest in improvement in guideline-
based pharmacotherapy, NYHA class and LVEF.
doi:10.1016/j.ijcard.2018.11.063
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Background: Two-dimensional (2D) speckle tracking echocardi-
ography (STE) enables assessment of global and regional strain of the
left ventricle (LV). Previous studies that strain imaging can ascertain
myocardial viability. However, these studies were conducted princi-
pally in Europe and analysis done using EchoPac (General-Electric-
Vingmed). There was no study using a different system (Philips-Qlab)
and in an Asian population.
Objective:
1) To determine the correlation between segmental LV strain (Philips
Qlab) and myocardial viability assessed by cardiac magnetic
resonance (CMR).
2) To determine the cut-off value for segmental strain for viability.
Methodology: 150 patients with ischemic cardiomyopathy who
had undergone viability assessment with CMR over a one-year
period (2015) were retrospectively screened. Cine MRI followed by
contrast enhanced MRI were done to assess LV function and the
extent of scar tissue in each LV segment. Non-viable myocardium
was defined as scar tissue of N 50% of wall thickness. Only 51 patients
had 2D echocardiography images of sufficiently good quality to
allow strain analysis. Analysis was done using the Philips Qlab
(version 10.0).
Results: Majority of subjects were male (84.3%) with mean age
of 58±10 years. 37.3% had diabetes, 76.5% had hypertension, 60.8%
had dyslipidaemia, and 49% were current smokers. All patients had
undergone coronary angiography and 56.9% had triple vessel disease.
70.6% had LV ejection fraction (EF) of b 40%. A weak but significant
correlation was found between global LV strain (GLS) and global
extent of scar tissue (R= 0.36, P=0.011). Mean segmental strain
values for viable and non-viable myocardial segments were -17.00±
5.36% and -4.88±2.41% respectively (Pb0.001). A cut-off strain value
of -7% had 84.07% sensitivity, 82.63% specificity, 56.3% positive
predictive value, 95.1% negative predictive value and 82.9% accuracy
in identifying non-viable myocardium.
Conclusion: Although GLS and total scar score had weak corre-
lation, a cut-off strain value of -7% had good accuracy in discrimi-
nating between viable and non-viable LV segments when compared
to contrast-enhanced CMR. Therefore, 2D STE may be an alternative
method for assessing myocardial viability in patients with good
echocardiography windows.
doi:10.1016/j.ijcard.2018.11.064
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Background: Myocardial bridging is a congenital anomaly in
which a portion of the coronary artery takes an intramuscular course
resulting in a tunneled segment. Myocardial bridges are present in
about one third of adults and most commonly localised in the middle
segment of the left anterior descending coronary artery (LAD).
Generally, myocardial bridging is described as benign condition with
good prognosis, although this condition still contributes to ischaemia
symptoms. The current gold standard for diagnosing it is by coronary
angiography with the typical "milking effect" and a "step down step
up" phenomenon induced by systolic compression of the tunneled
segment. The milking effect may be missed in thin bridges, hence
new imaging techniques such as computed tomography coronary
angiography (CTCA) may be required to detect it. To date, there is
no local data in Singapore reporting the prevalence of this frequent
coronary anomaly.
Objective: The purpose of this study was to determine the
prevalence of myocardial bridging in the study population and to
assess the characteristic of anatomical myocardial bridging defined
by CTCA.
Methods: A retrospective single centred study was conducted
involving 560 patients who underwent CTCA examination at National
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